Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Indices Open Flat
Tue, 29 Mar 09:30 am

Major Asian stock markets have opened the day on a negative note with stock market in China and Japan are trading lower by 1.2% and 0.7% respectively. Benchmark indices in US ended their previous session on a flattish note. The rupee is trading at 66.66 per US$.

Indian stock markets have opened the day on a flattish note. The BSE Sensex is trading lower by 12 points (down 0.1%) and NSE Nifty is trading lower by 2 points (down 0.01%). BSE Mid Cap is trading marginally lower by 0.1%. Whereas, BSE Small Cap is trading marginally higher by 0.1%. Major sectoral indices have opened the day on a mixed note with stocks from pharmaceutical sectors witnessing selling pressure. However, stocks from capital goods sector is witnessing buying interest.

As per an article in Livemint, Dr Reddy's Laboratories entered into a licensing agreement with US based XenoPort Inc Ltd. As per this agreement, Dr Reddy will be granted an exclusive right to develop and commercialize XenoPort Inc's clinical-stage oral new chemical entity (NCE) XP23829. Dr Reddy's will be making an upfront payment of US$ 47.5 million and US$ 2.5 million for transfer of certain clinical trial materials. Dr Reddy will hold exclusive rights to develop and market the product.

Dr Reddy's plans to develop the in-licensed drug for the treatment of moderate to severe chronic plague Psoriasis and may potentially develop for relapsing of multiple sclerosis (MS).

Under the terms of agreement, XenoPort will be eligible to receive amount up to US$ 190 million upon the achievement of regulatory milestones over the period of years. Further, XenoPort will also be eligible to receive upto US$ 250 m upon achievement of commercial milestones and royalty payments (in mid-teens) based on potential net sales of the drug in the US.

However, the agreement will be enforceable only upon receiving an approval from the US government under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act.

Reportedly, psoriasis is a chronic inflammatory autoimmune disorder that manifests in the skin and joints. The management stated that as many as 7.5 million Americans suffer from this condition. This in-licensed NCE is under Ph II development. As Dr Reddy takes the drug further for development, its R&D expenses are likely to surge in the upcoming period. Having said that, if the drug becomes successful this would be first innovative drug launched by Dr Reddy.

In another news update, Oil and Natural Gas Corporation (ONGC) intends to invest around Rs 340 billion over the next three years in two fields in the Krishna Godavari (KG) basin. The two fields are forecast to yield 50 billion cubic metres of gas and 23 million tonnes of crude oil over their lifetime.

The decision to invest in the KG basin comes after the governments offer for free market pricing for natural gas extracted from the deep sea blocks. Further the management stated that the company would be able to recover the cost of oilfield development before beginning to share profits with the government.

ONGC's director finance A.K. Srinivasan stated that he anticipates revenue to go up by $1,896 million and profit after tax by $585 million in 2020-21 as a result of oil and gas produced in the cluster. The company seeks to start production of gas from June 2019 and oil from March 2020.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian Indices Open Flat". Click here!


Views on News

Beware the Ides of March (Fast Profits Daily)

Mar 1, 2021

The month of March is usually difficult for traders. This time it will be even more so. Find out why in this video.

UTI Nifty200 Momentum 30 Index Fund: Aims to Benefit from Momentum Investing Strategy (Outside View)

Mar 1, 2021

PersonalFN analyses the features of UTI Nifty200 Momentum 30 Index Fund and explains the potential this fund has to offer to its investors.

How to Have a Perfectly Normal Day Even if Sensex Falls 2,000 Points (Profit Hunter)

Mar 1, 2021

How can someone witness a 2,000 point decline on the Sensex and still stay perfectly calm.

ITI Mid-Cap Fund: Investing in Potential Midcap Companies for Growth (Outside View)

Feb 26, 2021

PersonalFN analyses the features of ITI Mid-Cap Fund and explains the potential this fund has to offer to its investors.

NSE Glitch: Why Did the Market Go Up? (Fast Profits Daily)

Feb 26, 2021

In today's video, I'll discuss why thew stock market went up on Wednesday, 24 February 2021, when the NSE had to shut trading due to a technical glitch.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Mar 1, 2021 (Close)